Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation.
Bahr
Matthias J
MJ
Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Carl-Neuberg-Strasse 1, 30623 Hannover, Germany. matthias.bahr@gmx.de
Rosenau
J
J
Tietge
U J F
UJ
Caselitz
M
M
Hofmann
M W
MW
Klempnauer
J
J
Böker
K H W
KH
Strassburg
C P
CP
Manns
M P
MP
D000328:Adult; D006502:Budd-Chiari Syndrome / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005858:Germany; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D009196:Myeloproliferative Disorders / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors